【国家レベル二つの賞を受賞した】Onyxは 課題解決と持続可能な取り組みで医療AI領域の競争力を確立

Award judges highlighted that Frank Chuang has led Onyx down a high-value path rarely seen in Taiwan’s tech industry:
At a time when many chased the boom in consumer electronics, he deliberately avoided the red ocean and chose to enter the medical-grade market, with long certification cycles and high barriers. By focusing on own-brand products and highly customized solutions, Onyx has built a clear differentiation advantage.

Amid the global AI boom, he has consistently emphasized:

“AI specs can be copied. What can’t be copied is a deep understanding of clinical workflows.”

Onyx does not just sell hardware. By integrating ESG, cybersecurity, and system reliability into its solutions, the company helps leading hospitals in Europe and the U.S. address real clinical pain points.
In doing so, Onyx has built very high switching costs in the international market—creating a long-term moat that is difficult for price wars to break through.

With the EU’s CBAM and increasingly strict supply chain standards from global medical brands,
ESG has shifted from a “nice-to-have” bonus to an essential baseline.

At the 2025 TCSA, Onyx received:
🏆 Corporate Sustainability Performance – Taiwan’s Excellent Sustainable Companies Award
🏆 Corporate Sustainability Reporting – Gold Award

The judging committee recognized Onyx for:

Governance transparency and risk management
Strengthening board functions and enhancing risk control mechanisms.
Green medical computing
Developing low-power, high-efficiency medical AI platforms, while promoting internal digital transformation to reduce emissions.
Sustainable supply chain management
Managing everything from carbon footprint to labor rights in alignment with the audit standards of international medical brands.
These two TCSA awards send a clear signal to global customers and investors:
Onyx is not only a fast-growing medical AI company, but also a sustainable enterprise with controllable risk and long-term partnership value.